Prophylactic |
administration of |
agents affecting estrogen receptors and estrogen levels NEC V07.59 |
|
|
|
|
|
chemotherapeutic agent NEC V07.39 |
|
diphtheria antitoxin V07.2 |
|
estrogen receptor downregulators V07.59 |
|
|
|
gonadotropin-releasing hormone (GnRH) agonist V07.59 |
goserelin acetate (Zoladex) V07.59 |
immune sera (gamma globulin) V07.2 |
|
leuprolide acetate (leuprorelin) (Lupron) V07.59 |
megestrol acetate (Megace) V07.59 |
|
|
selective estrogen receptor modulators (SERMs) V07.51 |
|
|
|
|
|
hormone replacement (postmenopausal) V07.4 |
|
|
|
|
postmenopausal hormone replacement V07.4 |
|